AIP
CGON icon

Ameritas Investment Partners’s CG Oncology CGON Stock Holding History

Ameritas Investment Partners’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
4,840
+172
+4% +$9.74K 0.01% 999
2025
Q4 		$194K Hold
4,668
– – 0.01% 1268
2025
Q3 		$188K Sell
4,668
-807
-15% -$23.5K 0.01% 1278
2025
Q2 		$142K Hold
5,475
– – ﹤0.01% 1502
2025
Q1 		$134K Buy
5,475
+670
+14% +$18.8K ﹤0.01% 1510
2024
Q4 		$138K Hold
4,805
– – ﹤0.01% 1565
2024
Q3 		$181K Buy
4,805
+2,485
+107% +$87.1K 0.01% 1385
2024
Q2 		$73.2K Hold
2,320
– – ﹤0.01% 1928
2024
Q1 		$102K Buy
+2,320
New +$94.8K ﹤0.01% 1724

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameritas Investment Partners's CGON Position: Q1 2026 in Review

Ameritas Investment Partners increased its CG Oncology (CGON) stake by 3.7% in Q1 2026, buying an estimated $9.74K and bringing the position to 4,840 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #999.

Ameritas Investment Partners first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Ameritas Investment Partners held 4,840 shares of CG Oncology worth $328K as of Q1 2026.
  • Ameritas Investment Partners bought 172 CG Oncology shares in Q1 2026, an estimated $9.74K.
  • CG Oncology made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #999 holding.
  • Ameritas Investment Partners first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.